Latest AI Lifesciences news, analysis and insights from AIM Media House
Providence is using AI to identify cancer patients who may benefit from genetic testing, helping detect inherited cancer risks earlier and improve treatment decisions.
Labcorp's Q2 results show AI is supporting consumer health, specialty diagnostics, and clinical research as the company raises its 2026 outlook.
AI agent Ana already handles more than 160,000 patient calls per month across WellSpan's network, the company said.
GE HealthCare reported record orders growth in Q2 2026, driven by AI-enabled products and enterprise demand.
Mount Sinai Medical Center has expanded Epic's ambient AI documentation tool to inpatient nurses after physicians reduced charting time per encounter by nearly 30%.
AI-fueled demand for lab instruments and software helped Thermo Fisher beat earnings estimates and raise its full-year outlook.
WellSpan Health completed a 17-week migration of 300 applications and 7.5 petabytes of data to AWS, creating the foundation for AI across its clinical operations.
Allegheny Health Network will pilot UpDoc's AI platform to monitor diabetes patients between visits, aiming to speed insulin adjustments under physician supervision.
Bristol Myers Squibb is deploying NVIDIA's latest AI infrastructure to expand drug discovery, model development, and enterprise-wide research workflows.
The collaboration will target in-hospital transport of medications and specimens, along with AI-driven outpatient reception and guidance services.
Insilico Medicine and Bora Pharmaceuticals to combine AI drug discovery with pharmaceutical development and manufacturing capabilities.
Filevine has integrated Codes Health into its platform, bringing AI-powered medical record retrieval directly into legal workflows for plaintiff firms and litigation teams.
Chai Discovery will provide Novartis access to its Chai-3 AI model and platform to support therapeutic antibody discovery across multiple drug targets.
Healthcare's latest AI announcements focused on deployment, not experimentation or future promises.
IKS Health has completed its acquisition of TruBridge, combining AI, EHR, and revenue cycle technologies to expand its reach across U.S. healthcare providers.
The partnership integrates Anticoagulation Forum guidance into OpenEvidence's AI platform, giving clinicians evidence-based support for antithrombotic treatment decisions.
Brook.ai and SRHO will bring AI-enabled continuous care infrastructure to more than 275 hospitals, expanding remote care access through a national health system consortium.
Caris Life Sciences has launched Caris Detect, an AI-powered blood test that combines genomic sequencing and molecular data to identify cancer signals earlier.
AI drug discovery enters a pivotal year as late-stage clinical trials begin testing whether years of investment can translate into approved medicines.
Evernorth launched Pharmacy Forward, a $100 million AI-powered initiative aimed at reducing prescription delays, improving adherence, and enhancing specialty pharmacy operations.